Sr One Capital Management, LP Portfolio Holdings
Sr One Capital Management, LP
- $435 Million
- Q3 2025
Sr One Capital Management, LP has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $435 Million distributed in 12 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $193M, Crispr Therapeutics Ag with a value of $132M, Oric Pharmaceuticals, Inc. with a value of $53.9M, Design Therapeutics, Inc. with a value of $49.1M, and Nkarta, Inc. with a value of $6.9M.
Examining the 13F form we can see an increase of $156M in the current position value, from $279M to 435M.
Below you can find more details about Sr One Capital Management, LP portfolio as well as his latest detailed transactions.